Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
dermal absorption in vivo
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: No guideline was followed but well documented scientifically defensible approach was used to conduct the study.

Data source

Reference
Reference Type:
publication
Title:
Unnamed
Year:
1990

Materials and methods

Principles of method if other than guideline:
The percutaneous absorption of benzophenone was measured in vivo in monkey. Test item was applied to a lightly clipped 1 cm 2 area of abdominal skin at a concentration of 4 µg/cm 2. The application site was washed with soap and water as described above to remove residual material. The animals were then placed in metabolism cages to continue the urine collection for an additional 4 days. The amount of absorbed compound in the urine was determined by liquid scintillation counting.
GLP compliance:
not specified

Test material

Constituent 1
Chemical structure
Reference substance name:
Benzophenone
EC Number:
204-337-6
EC Name:
Benzophenone
Cas Number:
119-61-9
Molecular formula:
C13H10O
IUPAC Name:
benzophenone
Details on test material:
- Name of test material (as cited in study report): Benzophenone
- Radiochemical purity (if radiolabelling): 99.9%
- Specific activity (if radiolabelling): 5.4 mCi/mmoL
- Source: Pathfinder Laboratories, St. Louis, MO, USA
Radiolabelling:
yes

Test animals

Species:
monkey
Strain:
other: rhesus
Sex:
female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: California Primate Centre
- Age at study initiation: 10, 14, 19 and 19 years
- Individual metabolism cages: Yes

Administration / exposure

Type of coverage:
other: open-patch and closed-patch
Vehicle:
acetone
Duration of exposure:
24 h
Doses:
4 µg/cm2
No. of animals per group:
A total of 4 animals were used.
Control animals:
no
Details on study design:
DOSE PREPARATION
- Method for preparation of dose suspensions: The radiolabelled test item was diluted with acetone.

VEHICLE
- Amount(s) applied (volume or weight with unit): 10-20 µL/cm2.

TEST SITE
- Preparation of test site: The test site was lightly clipped.
- Area of exposure: 1 cm2 of abdominal skin
- Type of cover / wrap if used: plastic wrap or glass chamber.

SITE PROTECTION / USE OF RESTRAINERS FOR PREVENTING INGESTION: Monkeys were restrained in metabolic chairs for 24 hours.

REMOVAL OF TEST SUBSTANCE
- Washing procedures and type of cleansing agent: Washed with soap and water
- Time after start of exposure: 24 hours

SAMPLE COLLECTION
- Collection of urine and faeces: Urine samples for 4 days after the 24 hour exposure period.
- Terminal procedure: No.

ANALYSIS
- Method type(s) for identification: Liquid scintillation counting
- Liquid scintillation counting results (cpm) converted to dpm as follows: The amount of absorbed compound in the urine was determined by liquid scintillation counting, and results were corrected for total absorption as above by using a parenteral correction factor obtained in separate experiments.

Results and discussion

Signs and symptoms of toxicity:
not specified
Dermal irritation:
not specified
Percutaneous absorptionopen allclose all
Dose:
4 µg/cm2
Parameter:
percentage
Absorption:
ca. 43.8 %
Remarks on result:
other: Urine collection over 5 days; means and SD
Remarks:
Unoccluded site
Dose:
4 µg/cm2
Parameter:
percentage
Absorption:
ca. 68.7 %
Remarks on result:
other: Urine collection over 5 days; means and SD
Remarks:
Plastic wrap
Dose:
4 µg/cm2
Parameter:
percentage
Absorption:
>= 68.6 %
Remarks on result:
other: Urine collection over 5 days; means and SD
Remarks:
Glass chamber

Any other information on results incl. tables

Percutaneous absorption of Benzophenone in the monkeys:

Absorption (% of the applied dose)

 

Site occluded with

Compound

Unoccluded site

Plastic wrap

Glass chamber

Benzophenone

43.8 ± 7.5

68.7 ± 6.4

68.6 ± 4.6

Applicant's summary and conclusion

Conclusions:
After dermal application of [14C]benzophenone, approximately 70% was absorbed in rhesus monkeys within 24 hours.
Executive summary:

The percutaneous absorption of benzophenone was measured in vivo in monkey. Test item was applied to a lightly clipped 1 cm 2 area of abdominal skin at a concentration of 4 µg/cm 2. The application site was washed with soap and water as described above to remove residual material. The animals were then placed in metabolism cages to continue the urine collection for an additional 4 days. The amount of absorbed compound in the urine was determined by liquid scintillation counting. Approximately 70% was absorbed in rhesus monkeys within 24 hours.